Skip to main navigation menu Skip to main content Skip to site footer

CLINICAL FEATURES AND MANAGEMENT OF CERVICAL INTRAEPITHELIAL NEOPLASIA IN PERSISTENT HPV INFECTION

PDF

Abstract

Cervical intraepithelial neoplasia (CIN) is a precancerous condition strongly associated with persistent human papillomavirus (HPV) infection. The most effective way to prevent cervical cancer is early diagnosis and timely treatment of preinvasive lesions of the cervical epithelium. Cervical intraepithelial neoplasia (CIN) is characterized by potentially precancerous transformation and abnormal growth (dysplasia) of squamous epithelium on the surface of the cervix.


References

  1. Gafurova F.A., Artickhodzhaeva G.Sh. Mixed vulvovaginal infections. Experience in the use of combined local therapy // Scientific and practical journal "News of dermatovenerology and reproductive health" - Tashkent 2017.- No. 3-A No.1, pp.110-111.
  2. Dobrokhotova Yu. E., Venediktova M. G., Sarantsev A. N., Morozova K. V., Suvorova V. A. A modern approach to the treatment of moderate and severe cervical epithelial dysplasia against the background of human papillomavirus with the use of antiviral therapy. 2016. No. 4. pp. 52-56.
  3. Clinical recommendations. Benign and precancerous diseases of the cervix from the perspective of cancer prevention. M., 2017. 55 p.
  4. Rogovskaya S. I., Ledina A.V., Ipastova I. D. HPV infection: combination therapy. Effective strategies for the combined treatment of HPV-associated genetic diseases // Status praesens. 2017. 16 p.
  5. Santesso N, Mustafa RA, Wiercioch W, et al. Systematic reviews and meta-analyses of benefits and harms of cryotherapy, LEEP, and cold knife conization to treat cervical intraepithelial neoplasia. Int J Gynaecol Obstet. 2016;132(3):266-271.
  6. American Society of Clinical Oncology. Cervical cancer: statistics. Cancer.net. http://www.cancer.net/cancer-types/cervical-cancer/statistics. Published July 2017. Accessed April 14, 2018.
  7. Garland SM, Kjaer SK, Muñoz N, et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63(4):519-527. doi:10.1093/cid/ciw354PubMedGoogle ScholarCrossref

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.